Commission mouvements anormaux de lSociété Française de Neurologie Pédiatrique, Montpellier, France.
Eur J Neurol. 2012 Oct;19(10):1292-9. doi: 10.1111/j.1468-1331.2011.03649.x. Epub 2012 Jan 31.
Management of childhood dystonia differs in certain respects from that of adult dystonia: (i) childhood dystonia is more often secondary than primary; (ii) mixed motor disorders are frequent; (iii) in children, the course of dystonia may be influenced by ongoing brain maturation and by the remarkable plasticity of the young brain; (iv) drug tolerability and effectiveness can be different in children; (v) the therapeutic strategy must be discussed with both the patient and his or her parents; and (vi) the child's education must be taken into account. Based on a systematic review of the literature through June 2011 and on our personal experience, we propose a therapeutic approach to childhood dystonia. After a detailed clinical evaluation and a comprehensive work-up to rule out a treatable cause of dystonia, symptomatic treatment may include various drugs, local botulinum toxin injections, and deep brain stimulation, in addition to rehabilitation.
(i)儿童肌张力障碍多为继发性而非原发性;(ii)混合性运动障碍较为常见;(iii)在儿童中,肌张力障碍的病程可能受脑发育的影响和年轻大脑的显著可塑性;(iv)药物的耐受性和疗效在儿童中可能不同;(v)治疗策略必须与患者及其父母讨论;(vi)必须考虑到儿童的教育。根据截至 2011 年 6 月的文献系统评价和我们的个人经验,我们提出了一种治疗儿童肌张力障碍的方法。在详细的临床评估和全面的检查以排除可治疗的肌张力障碍病因后,对症治疗可能包括各种药物、局部肉毒毒素注射和深部脑刺激,以及康复。